Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib

Po Shen Ko, Yuan Bin Yu, Yao Chung Liu, Yi Tsui Wu, Man Hsin Hung, Jyh Pyng Gau, Chia Jen Liu, Liang Tsai Hsiao, Po Min Chen, Tzeon Jye Chiou, Chun Yu Liu, Jin Hwang Liu

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences